T1	Condition 19 43	Major Depressive Episode
T2	Measurement 48 115	Diagnostic Statistical Manual of Mental Disorder - IV (TR) criteria
T3	Value 0 5	Meets
R1	Has_value Arg1:T2 Arg2:T3	
R2	AND Arg1:T1 Arg2:T2	
T4	Condition 140 161	agitation /aggression
T5	Qualifier 117 139	Clinically significant
T6	Undefined_semantics 117 139	Clinically significant
R3	Has_qualifier Arg1:T4 Arg2:T5	
T8	Multiplier 186 220	frequency of agitation /aggression
T7	Condition 199 220	agitation /aggression
R4	AND Arg1:T8 Arg2:T7	
T9	Measurement 240 243	NPI
R5	AND Arg1:T8 Arg2:T9	
T10	Value 248 263	Very frequently
R6	Has_value Arg1:T9 Arg2:T10	
T11	Multiplier 276 310	frequency of agitation /aggression
T12	Condition 289 310	agitation /aggression
R7	AND Arg1:T11 Arg2:T12	
T13	Measurement 330 333	NPI
T14	Value 338 348	Frequently
R8	Has_value Arg1:T13 Arg2:T14	
T15	Measurement 403 406	NPI
T16	Value 411 419	Moderate
T17	Value 426 432	Marked
*	OR T16 T17
T18	Scope 410 433	'Moderate', or 'Marked'
R9	Has_scope Arg1:T15 Arg2:T18	
T19	Qualifier 358 383	severity of the agitation
T20	Condition 374 383	agitation
R10	AND Arg1:T19 Arg2:T20	
R11	AND Arg1:T19 Arg2:T15	
T21	Condition 458 467	delusions
T22	Qualifier 435 457	Clinically significant
T23	Multiplier 492 514	frequency of delusions
T24	Condition 505 514	delusions
R12	AND Arg1:T23 Arg2:T24	
T25	Measurement 534 537	NPI
T26	Value 542 557	Very frequently
R13	Has_value Arg1:T25 Arg2:T26	
R14	AND Arg1:T23 Arg2:T25	
R15	Has_qualifier Arg1:T21 Arg2:T22	
T27	Multiplier 570 592	frequency of delusions
T28	Condition 583 592	delusions
T29	Measurement 612 615	NPI
T30	Value 620 630	Frequently
T31	Qualifier 640 665	severity of the delusions
T32	Condition 656 665	delusions
R16	AND Arg1:T31 Arg2:T32	
T33	Measurement 685 688	NPI
T34	Value 693 701	Moderate
T35	Value 708 714	Marked
*	OR T34 T35
T36	Scope 692 715	'Moderate', or 'Marked'
R17	Has_scope Arg1:T33 Arg2:T36	
R18	Has_value Arg1:T29 Arg2:T30	
R19	AND Arg1:T27 Arg2:T29	
R20	AND Arg1:T31 Arg2:T33	
T37	Condition 740 754	hallucinations
T38	Qualifier 717 739	Clinically significant
R21	Has_qualifier Arg1:T37 Arg2:T38	
T39	Multiplier 779 806	frequency of hallucinations
T40	Condition 792 806	hallucinations
R22	AND Arg1:T39 Arg2:T40	
T41	Measurement 826 829	NPI
T42	Value 834 849	Very frequently
R23	Has_value Arg1:T41 Arg2:T42	
T43	Multiplier 862 889	frequency of hallucinations
T44	Condition 875 889	hallucinations
R24	AND Arg1:T43 Arg2:T44	
T45	Measurement 909 912	NPI
T46	Value 917 927	Frequently
T47	Qualifier 937 967	severity of the hallucinations
T48	Condition 953 967	hallucinations
R25	AND Arg1:T47 Arg2:T48	
T49	Measurement 987 990	NPI
T50	Value 995 1003	Moderate
T51	Value 1010 1016	Marked
*	OR T50 T51
T52	Scope 994 1017	'Moderate', or 'Marked'
R26	Has_scope Arg1:T49 Arg2:T52	
R27	AND Arg1:T47 Arg2:T49	
R28	Has_value Arg1:T45 Arg2:T46	
R29	AND Arg1:T43 Arg2:T45	
R30	AND Arg1:T39 Arg2:T41	
*	OR T8 T11 T19
R31	AND Arg1:T11 Arg2:T13	
T53	Scope 186 433	frequency of agitation /aggression as assessed by the NPI is 'Very frequently', or 2) the frequency of agitation /aggression as assessed by the NPI is 'Frequently' AND the severity of the agitation as assessed by the NPI is 'Moderate', or 'Marked'
R32	Has_scope Arg1:T4 Arg2:T53	
T54	Scope 492 715	frequency of delusions as assessed by the NPI is 'Very frequently', or 2) the frequency of delusions as assessed by the NPI is 'Frequently' AND the severity of the delusions as assessed by the NPI is 'Moderate', or 'Marked'
R33	Has_scope Arg1:T21 Arg2:T54	
*	OR T23 T27 T31
*	OR T47 T43
T55	Scope 779 1017	frequency of hallucinations as assessed by the NPI is 'Very frequently', or 2) the frequency of hallucinations as assessed by the NPI is 'Frequently' AND the severity of the hallucinations as assessed by the NPI is 'Moderate', or 'Marked'
R34	Has_scope Arg1:T37 Arg2:T55	
T56	Drug 1034 1058	psychotropic medications
T57	Temporal 1059 1096	in the 2 weeks prior to randomization
T58	Reference_point 1083 1096	randomization
R35	Has_index Arg1:T57 Arg2:T58	
T59	Condition 1143 1151	dementia
T60	Procedure 1128 1151	treatments for dementia
R36	AND Arg1:T60 Arg2:T59	
T61	Drug 1153 1158	ChEIs
T62	Drug 1163 1172	memantine
T63	Scope 1153 1172	ChEIs and memantine
R37	Has_scope Arg1:T60 Arg2:T63	
T64	Drug 1175 1229	selective serotonin reuptake inhibitor antidepressants
T65	Drug 1235 1244	trazodone
R38	Has_temporal Arg1:T56 Arg2:T57	
T66	Negation 1097 1118	with the exception of
*	OR T65 T64 T60
T67	Scope 1128 1244	treatments for dementia (ChEIs and memantine), selective serotonin reuptake inhibitor antidepressants, and trazodone
R39	Has_negation Arg1:T67 Arg2:T66	
R40	Has_scope Arg1:T56 Arg2:T67	
T68	Context_Error 1245 1313	(if used as an aid to facilitate sleep and not as an antidepressant)
T69	Drug 1315 1334	other psychotropics
T70	Drug 1358 1372	antipsychotics
T71	Negation 1336 1357	with the exclusion of
R41	Has_negation Arg1:T70 Arg2:T71	
R42	AND Arg1:T69 Arg2:T70	
T72	Qualifier 1378 1384	stable
T73	Temporal 1385 1397	for 3 months
R43	Has_temporal Arg1:T72 Arg2:T73	
R44	Has_qualifier Arg1:T69 Arg2:T72	
*	OR T69 T56
T74	Drug 1544 1559	methylphenidate
T75	Drug 1644 1659	methylphenidate
T76	Subjective_judgement 1730 1758	as judged by study physician
T77	Drug 1777 1850	medication that would prohibit the safe concurrent use of methylphenidate
T78	Drug 1835 1850	methylphenidate
T79	Temporal 1817 1827	concurrent
T80	Observation 1799 1807	prohibit
R45	Has_temporal Arg1:T78 Arg2:T79	
R46	Has_context Arg1:T78 Arg2:T80	
T81	Drug 1859 1887	monoamine oxidase inhibitors
T82	Drug 1892 1917	tricyclic antidepressants
T83	Scope 1859 1917	monoamine oxidase inhibitors and tricyclic antidepressants
*	OR T82 T81
R47	Subsumes Arg1:T77 Arg2:T83	
T84	Procedure 1934 1961	psychiatric hospitalization
T85	Observation 1919 1927	Need for
T86	Temporal 1928 1933	acute
R48	Has_temporal Arg1:T84 Arg2:T86	
R49	Has_context Arg1:T84 Arg2:T85	
T87	Condition 1968 1976	suicidal
*	OR T84 T87
T88	Condition 1978 2003	Uncontrolled hypertension
T89	Qualifier 1978 1990	Uncontrolled
R50	Has_qualifier Arg1:T88 Arg2:T89	
T90	Condition 2005 2030	medication non-compliance
T91	Temporal 2034 2047	past 3 months
T92	Measurement 2055 2072	diastolic reading
T93	Value 2076 2079	105
R51	Has_value Arg1:T92 Arg2:T93	
T94	Context_Error 2055 2072	diastolic reading
T95	Measurement 2095 2143	compartment pressure of the rectus sheath (CPRS)
T96	Qualifier 2080 2143	as verified by compartment pressure of the rectus sheath (CPRS)
R52	AND Arg1:T96 Arg2:T95	
R53	Has_qualifier Arg1:T92 Arg2:T96	
R54	Has_temporal Arg1:T90 Arg2:T91	
T97	Scope 2005 2143	medication non-compliance or past 3 months with a diastolic reading of 105 as verified by compartment pressure of the rectus sheath (CPRS)
R55	Has_scope Arg1:T88 Arg2:T97	
T98	Condition 2158 2181	coronary artery disease
T99	Qualifier 2146 2157	Symptomatic
R56	Has_qualifier Arg1:T98 Arg2:T99	
T100	Temporal 2226 2250	at the time of screening
T101	Reference_point 2233 2250	time of screening
R57	Has_index Arg1:T100 Arg2:T101	
T102	Condition 2297 2322	unintentional weight loss
T103	Qualifier 2285 2296	significant
T104	Undefined_semantics 2285 2296	significant
R58	Has_qualifier Arg1:T102 Arg2:T103	
T105	Condition 2252 2268	Lack of appetite
R59	AND Arg1:T105 Arg2:T102	
T106	Qualifier 2323 2359	as determined by the study physician
T107	Temporal 2360 2384	in the last three months
R60	Has_temporal Arg1:T105 Arg2:T107	
R61	Has_qualifier Arg1:T102 Arg2:T106	
T108	Qualifier 2386 2397	Significant
T109	Undefined_semantics 2386 2397	Significant
T110	Condition 2398 2423	communicative impairments
R62	Has_qualifier Arg1:T110 Arg2:T108	
T111	Undefined_semantics 2398 2423	communicative impairments
T112	Post-eligibility 2425 2539	Current participation in a clinical trial or in any study that may add significant burden or affect study outcomes
T113	Condition 2541 2556	Hyperthyroidism
T114	Condition 2567 2583	arteriosclerosis
T115	Qualifier 2558 2566	advanced
R63	Has_qualifier Arg1:T114 Arg2:T115	
T116	Condition 2597 2619	cardiovascular disease
T117	Qualifier 2585 2596	symptomatic
R64	Has_qualifier Arg1:T116 Arg2:T117	
T118	Qualifier 2621 2628	serious
T119	Condition 2629 2661	structural cardiac abnormalities
R65	Has_qualifier Arg1:T119 Arg2:T118	
T120	Condition 2663 2677	cardiomyopathy
T121	Condition 2687 2713	heart rhythm abnormalities
T122	Qualifier 2679 2686	serious
R66	Has_qualifier Arg1:T121 Arg2:T122	
T123	Observation 2720 2734	family history
T124	Condition 2738 2750	sudden death
T125	Condition 2754 2785	death related to heart problems
T126	Qualifier 2760 2785	related to heart problems
R67	Has_qualifier Arg1:T125 Arg2:T126	
*	OR T124 T125
T127	Scope 2738 2785	sudden death or death related to heart problems
R68	Has_context Arg1:T127 Arg2:T123	
*	OR T121 T127 T120 T119 T116 T114 T113
T128	Condition 2787 2795	Glaucoma
T129	Condition 2797 2813	pheochromocytoma
T130	Condition 2837 2853	hypersensitivity
T131	Drug 2857 2890	methylphenidate or its excipients
R69	AND Arg1:T130 Arg2:T131	
T132	Drug 2876 2890	its excipients
R70	AND Arg1:T131 Arg2:T132	
*	OR T131 T132
T133	Observation 2827 2836	suspected
T134	Observation 2818 2823	known
*	OR T133 T134
T135	Scope 2818 2836	known or suspected
R71	Has_scope Arg1:T130 Arg2:T135	
*	OR T130 T129 T128
T136	Condition 2892 2934	Central Nervous System (CNS) abnormalities
T137	Condition 2942 2959	cerebral aneurysm
R72	Subsumes Arg1:T136 Arg2:T137	
T138	Condition 2974 2996	vascular abnormalities
T139	Condition 3005 3015	vasculitis
R73	Subsumes Arg1:T138 Arg2:T139	
T140	Condition 3032 3038	stroke
T141	Temporal 3019 3031	pre-existing
R74	Has_temporal Arg1:T140 Arg2:T141	
T142	Condition 3040 3050	motor tics
T143	Observation 3056 3070	family history
T144	Condition 3087 3106	Tourette's syndrome
T145	Condition 3108 3116	seizures
T146	Condition 3118 3129	convulsions
T147	Observation 3074 3083	diagnosis
*	OR T147 T143
T148	Scope 3056 3083	family history or diagnosis
R75	Has_scope Arg1:T144 Arg2:T148	
T149	Condition 3131 3139	epilepsy
*	OR T149 T146
T150	Scope 3118 3139	convulsions, epilepsy
R76	Subsumes Arg1:T145 Arg2:T150	
T151	Qualifier 3145 3153	abnormal
T152	Condition 3154 3158	EEGs
R77	Has_qualifier Arg1:T152 Arg2:T151	
*	OR T136 T138 T140 T142 T144 T145 T152
T153	Post-eligibility 3160 3299	Any condition that, in the opinion of the study physician, makes it medically inappropriate or risky for the patient to enroll in the trial
